Hu, Yuemei <br/><br/>
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  2019 
 - 1066-1069 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.1080/21645515.2019.1581541  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Viral<br/>Double-Blind Method<br/>Female<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Immunogenicity, Vaccine<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--prevention & control<br/>Injections, Intramuscular<br/>Male<br/>Middle Aged<br/>Seroconversion<br/>Vaccines, Inactivated--immunology<br/>Young Adult